Using Plasma Amyloid Beta Oligomer to Screen in Alzheimer's Disease: A Pilot Study. [PDF]
Hsu PC, Yang JY, Huang LC, Yang YH.
europepmc +1 more source
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi +6 more
wiley +1 more source
Amyloid Beta Biomarkers and Their Association with Cognitive Impairment Across Vitamin D Strata: A Cross-Sectional Study in an Older Adult South Indian Population. [PDF]
Ramashetty R +4 more
europepmc +1 more source
Brain interstitial fluid pharmacokinetics and therapeutic effect of a BBB penetrating amyloid beta antibody measured by microdialysis. [PDF]
Wik E +6 more
europepmc +1 more source
Age-related increase in plasma p-tau217 in amyloid-beta-negative cognitively unimpaired individuals affects diagnostic interpretation. [PDF]
Mammel AE +11 more
europepmc +1 more source
Amyloid Beta Oligomers as Early Triggers of Neuronal Cytoskeleton Dysfunction in Alzheimer's Disease. [PDF]
Gasca-Martínez Y +3 more
europepmc +1 more source
A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer's disease. [PDF]
Chen T +13 more
europepmc +1 more source
Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's disease. [PDF]
Nonino F +10 more
europepmc +1 more source

